Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
701
DELISTED
MRC Global
MRC
| $18.9M | 0.03% |
1,475,159
-56,900
| -4% | -$745K |
|
|
WCC
702
WESCO International
WCC
$17.5B
| $18.6M | 0.03% |
102,974
+71,400
| +226% | +$13.5M |
|
703
Titan International
TWI
$438M
| $18.6M | 0.03% |
2,743,587
+27,616
| +1% | +$199K |
|
704
Hecla Mining
HL
$11.9B
| $18.6M | 0.03% |
3,788,100
+885,900
| +31% | +$5.29M |
|
705
Univest Financial
UVSP
$1.19B
| $18.6M | 0.03% |
628,689
-22,200
| -3% | -$660K |
|
706
Twist Bioscience
TWST
$7.86B
| $18.5M | 0.03% |
398,708
+184,398
| +86% | +$8.33M |
|
707
Central Pacific Financial
CPF
$1B
| $18.5M | 0.03% |
637,053
+66,053
| +12% | +$1.96M |
|
708
Vanda Pharmaceuticals
VNDA
$304M
| $18.5M | 0.03% |
3,853,799
-157,723
| -4% | -$757K |
|
709
Hudbay
HBM
$11.8B
| $18.4M | 0.03% |
2,276,609
+238,500
| +12% | +$2.14M |
|
710
SandRidge Energy
SD
$516M
| $18.4M | 0.03% |
1,574,012
-4,000
| -0.3% | -$46.2K |
|
711
Parsons
PSN
$5.08B
| $18.4M | 0.03% |
199,500
+28,900
| +17% | +$2.95M |
|
712
BlackRock Flexible Income ETF
BINC
$16.3B
| $18.3M | 0.03% |
351,792
-273,852
| -44% | -$14.4M |
|
713
Federal Realty Investment Trust
FRT
$10.3B
| $18.3M | 0.03% |
163,414
-113,986
| -41% | -$12.9M |
|
714
Paylocity
PCTY
$8.1B
| $18.3M | 0.03% |
91,700
-68,300
| -43% | -$13.1M |
|
715
Castle Biosciences
CSTL
$933M
| $18.3M | 0.03% |
685,000
+195,438
| +40% | +$5.95M |
|
716
Fortuna Silver Mines
FSM
$3.1B
| $18.2M | 0.03% |
4,233,900
+520,100
| +14% | +$2.48M |
|
717
Mobileye
MBLY
$7.57B
| $18.1M | 0.03% |
907,417
-275,883
| -23% | -$4.34M |
|
718
Amgen
AMGN
$226B
| $18M | 0.03% |
+69,045
| New | +$20.5M |
|
719
Ovintiv
OVV
$17.2B
| $17.9M | 0.03% |
442,494
+30,266
| +7% | +$1.26M |
|
720
Genworth Financial
GNW
$3.77B
| $17.9M | 0.03% |
2,558,600
+283,700
| +12% | +$2.04M |
|
721
Weis Markets
WMK
$1.77B
| $17.9M | 0.03% |
263,636
-16,200
| -6% | -$1.11M |
|
722
Sweetgreen
SG
$721M
| $17.8M | 0.03% |
555,800
-1,283,700
| -70% | -$47.8M |
|
|
HBI
723
DELISTED
Hanesbrands
HBI
| $17.8M | 0.03% |
2,185,401
+381,201
| +21% | +$3M |
|
724
Keysight
KEYS
$60.5B
| $17.7M | 0.03% |
+110,299
| New | +$17.8M |
|
725
Expeditors International
EXPD
$24.3B
| $17.7M | 0.03% |
159,516
-80,400
| -34% | -$9.59M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.